FdaApplication
ANDA 210434
Identifiers
- fda_app_no: ANDA210434
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2018-09-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALBENDAZOLE | ALBENDAZOLE | 200MG | TABLET;ORAL |
1 product